drugset
drugset / Trial / NCT04283695

To Investigate the Absorption, Metabolism, Excretion, Absolute Bioavailability, and Immunogenicity of GX-I7 in Healthy Volunteers

NCT04283695 ↗

Phase 0 Unknown 12 enrolled Seoul National University Hospital
Non-randomizedSingle-groupOpen-labelBasic science

Summary

A Phase 1, open-labeled, single-dose, one-sequence, one-period, 3-part study to investigate the absorption, metabolism, excretion, absolute bioavailability, and immunogenicity of GX-I7 in healthy volunteers

Timeline

Start
2019-07-03
Primary completion
2019-08-30
Completion
2020-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject NT-I7 Protein / enzyme biologic 40 ug Intramuscular
Subject NT-I7 Protein / enzyme biologic 60 ug/kg Intramuscular

Indications

leukopenia